Literature DB >> 16721749

Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.

Chi-Chou Huang1, Ya-Wen Cheng, Meng-Cheng Chen, Yu-Shyang Lin, Ming-Chih Chou, Huei Lee.   

Abstract

Epidemiological studies consistently find associations between colorectal cancer and cigarette smoking; however, there are little molecular data supporting the association. To examine the relationship between cigarette smoking and colorectal cancer, we compared p53 mutation patterns in colorectal tumors from smokers and nonsmokers. In this study, 153 tumor tissues from colorectal cancer patients, including 63 smokers and 90 nonsmokers, were examined for p53 mutation and p53 protein expression by direct sequencing and immunohistochemistry (IHC), respectively. p53 mutations were detected in 77 of 153 (50.3%) colorectal tumors, and no difference was observed in the p53 mutation frequencies in tumors from smokers and nonsmokers (33 of 63, 50.8% for smokers vs. 44 of 90, 48.9% for nonsmokers, P = 0.743). IHC showed that p53-immunoreactive tumors were positively correlated with p53-mutated tumors (P < 0.0001). G:C-->A:T transition and G:C-->T:A transversion were the predominant types of mutations detected in the tumor p53 genes. G:C-->A:T mutation was relatively more common in nonsmokers than in smokers (93.5% for nonsmokers vs. 77.3% for smokers), although this difference was not significant. The frequency of deletion mutation in smoker tumors, however, was significantly higher than that in nonsmoker tumors (7 of 33, 21.2% for smokers vs. 1 of 44, 2.3% for nonsmokers, P = 0.01). Although there were only a few cases of p53 deletion mutation in this study, the observation of a higher frequency of p53 deletion mutation in smoker tumors supports the association between cigarette smoking and the development of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721749     DOI: 10.1002/em.20222

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  5 in total

1.  Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis.

Authors:  Ke Chen; Guanggai Xia; Changhua Zhang; Yunwei Sun
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.

Authors:  Peter F Rambau; Michael Odida; Henry Wabinga
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

3.  Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.

Authors:  Nadine Jackson McCleary; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al Benson; Richard Goldberg; Jeffrey A Meyerhardt
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

4.  Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.

Authors:  Yasuaki Enokida; Kimihiro Shimizu; Jun Atsumi; Seiichi Kakegawa; Yoshiaki Takase; Kyoichi Kaira; Hideaki Yashima; Takuya Araki; Seshiru Nakazawa; Yoichi Ohtaki; Toshiteru Nagashima; Lezhava Alexander; Kengo Usui; Toshihisa Ishikawa; Yoshihide Hayashizaki; Izumi Takeyoshi
Journal:  Cancer Med       Date:  2016-05-26       Impact factor: 4.452

5.  Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.

Authors:  Xia Li; Jie Wei; Yixiong Liu; Peifeng Li; Linni Fan; Yingmei Wang; Mingyang Li; Danhui Zhao; Zhou Yu; Jing Ye; Ying Guo; Qingguo Yan; Shuangping Guo; Zhe Wang
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.